Archive

Archive for the ‘Stem Cell Technology’ Category

$10M Grant to study Retinal Disease, Case Western Reserve University

December 29th, 2010 No comments

Case Western Reserve University has received  $10M over 5 years to study retinal disease. Read more…

Blastomere Technology Agreement with Roslin Institute, Advanced Cell Technology (ACTC.OB)

December 28th, 2010 No comments

ACTC.OB has entered into a Memorandum of Understanding with Roslin Cells LTD (“Roslin Cells”) of Scotland, Read more…

Cell Transfer Agreement for hES Cell Lines, BioTime (AMEX: BTX)

December 23rd, 2010 No comments

BTX announced a Material Transfer Agreement (MTA) with the University of California (UC) system Read more…

Merry Christmas and Happy Holiday to All

December 23rd, 2010 No comments

A Christmas wish is the ideal way to pray for peace for all and better market dynamics. Read more…

Orphan Drug Designation filed in EU of Stargardt’s Disease, Advanced Cell Technology (ACTC.OB)

December 23rd, 2010 No comments

ACTC.OB has filed for Orphan Drug Designation with the European Medicines Agency (EMA) for its Retinal Pigment Epithelial (RPE) Cells Read more…

£10M Funding completing, ReNeuron (LON: RENE)

December 20th, 2010 No comments

LSE: RENE.L fund raising completing at £10M

Read more…

Klein to lead CIRM for six months

December 16th, 2010 No comments

Bob Klein, will continue as the chairman of the oversight board for up to 6 months Read more…

Depression Trial IND approval, Neuralstem (NYSE Amex: CUR)

December 16th, 2010 No comments

CUR received an Investigational New Drug (IND) application approval to initiate a Phase Ia safety trial to test NSI-189 Read more…

$22.5M Public Offering closes, Aastrom Biosciences (ASTM)

December 16th, 2010 No comments

ASTM has completed a public offering at a price of $2.25 per unit Read more…

States and Federal Funding ESC Research

December 15th, 2010 No comments

Study finds federal government still contributes more overall funding of stem cell research. Read more…